Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Chief Financial Officer | July 02, 2026 | July 07, 2026 |
| Orthofix Medical Inc.OFIX · Entity 1975 | CFO | April 11, 2022 | April 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 399,566 |
Reported balance
After 2026-07-02 transaction · row 1
1 source rowRow 1 · 2026-07-02 · Tax withholding · Disposed 12,749 · Balance 399,566 F1: Shares withheld for payment of tax liability upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of tax liability upon vesting of restricted stock units.
Orthofix Medical Inc.
Report date April 11, 2022 · Filed April 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 107,679 |
Reported balance
After 2022-04-11 transaction · row 1
1 source rowRow 1 · 2022-04-11 · Grant · Acquired 14,937 · Balance 107,679 F1: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2026 Filed Jul 7, 2026 12:53 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 12,749 | $3.95 | $50,358.55 |
DisclosureSEC source: 0001376339-26-000057 · wk-form4_1783428779.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,566 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 96,363 | $4.50 | $433,633.50 |
DisclosureSEC source: 0001618861-26-000006 · wk-form4_1773351285.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 412,315 F2 · shares: The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:34 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionCommon Stock | 243,000 | $4.50 | $1,093,500.00 |
DisclosureSEC source: 0001618861-26-000006 · wk-form4_1773351285.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 508,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on July 5, 2023. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:47 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 62,068 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001618861-26-000004 · wk-form4_1772837254.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,309 Underlying: Common Stock · 62,068 shares Expires 2033-03-03 F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:47 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 74,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001618861-26-000004 · wk-form4_1772837254.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,678 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. F2 · balance_after: Includes 3,491 shares acquired on January 30, 2026 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 21:59 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 12,749 | $6.34 | $80,828.66 |
DisclosureSEC source: 0001376339-25-000080 · wk-form4_1751925593.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,024 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:44 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 36,486 | $0.00 Strike: $8.30 | $0.00 |
DisclosureSEC source: 0001376339-25-000017 · wk-form4_1741218255.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,241 Underlying: Common Stock · 36,486 shares Expires 2032-03-03 F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:44 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 45,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-25-000017 · wk-form4_1741218255.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,773 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. F2 · balance_after: Includes an aggregate of 6,915 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 21:58 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 12,749 | $6.79 | $86,565.71 |
DisclosureSEC source: 0001376339-24-000060 · wk-form4_1720648683.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,929 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 70,755 | $0.00 Strike: $8.63 | $0.00 |
DisclosureSEC source: 0001376339-24-000015 · wk-form4_1709681229.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,755 Underlying: Common Stock · 70,755 shares Expires 2031-03-01 F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 58,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-24-000015 · wk-form4_1709681229.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,678 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:01 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | PurchaseCommon Stock | 5,000 | $7.16 | $35,786.50 |
DisclosureSEC source: 0001376339-23-000071 · wk-form4_1700690463.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,200 Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 22:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 94,000 | $0.00 Strike: $6.44 | $0.00 |
DisclosureSEC source: 0001376339-23-000059 · wk-form4_1688681577.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,000 Underlying: Common Stock · 94,000 shares Expires 2030-07-05 F2 · shares: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 22:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 97,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-23-000059 · wk-form4_1688681577.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,200 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 20:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024287 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,679 F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022. Read SEC document |
| April 02, 2022 Filed Apr 5, 2022 23:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 363 | $33.04 | $11,993.52 |
DisclosureSEC source: 0001209191-22-023342 · doc4.xml · nonDerivative · entry 4 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,742 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 385 | $33.04 | $12,720.40 |
DisclosureSEC source: 0001209191-22-023342 · doc4.xml · nonDerivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,105 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 1,317 | $33.04 | $43,513.68 |
DisclosureSEC source: 0001209191-22-023342 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,490 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 867 | $33.04 | $28,645.68 |
DisclosureSEC source: 0001209191-22-023342 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,807 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:45 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 22,131 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006829 · doc4.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,131 Underlying: Common Stock · 22,131 shares Expires not disclosed F2 · derivative.exercise_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the "Product Revenue Vesting Percentage"), as modified by a total shareholder return ("TSR") modifier (the "TSR Modifier"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group. F2 · derivative.expiration_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the "Product Revenue Vesting Percentage"), as modified by a total shareholder return ("TSR") modifier (the "TSR Modifier"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:45 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 22,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006829 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,674 F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, February 1, 2022. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 21:05 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 1,400 | $30.05 | $42,070.00 |
DisclosureSEC source: 0001209191-21-065779 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,543 Read SEC document |
| July 03, 2021 Filed Jul 7, 2021 21:13 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 373 | $40.48 | $15,099.04 |
DisclosureSEC source: 0001209191-21-045855 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,370 Read SEC document |
| April 02, 2021 Filed Apr 5, 2021 22:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 363 | $42.93 | $15,583.59 |
DisclosureSEC source: 0001209191-21-025417 · doc4.xml · nonDerivative · entry 5 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,478 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 13,394 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025417 · doc4.xml · derivative · entry 6 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,394 Underlying: Common Stock · 13,394 shares Expires not disclosed F2 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES) as of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. F2 · derivative.expiration_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES) as of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 867 | $42.93 | $37,220.31 |
DisclosureSEC source: 0001209191-21-025417 · doc4.xml · nonDerivative · entry 4 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,841 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 3,029 | $42.93 | $130,034.97 |
DisclosureSEC source: 0001209191-21-025417 · doc4.xml · nonDerivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,708 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 385 | $42.93 | $16,528.05 |
DisclosureSEC source: 0001209191-21-025417 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,737 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 13,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025417 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,122 F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2021. Read SEC document |
| July 08, 2020 Filed Jul 9, 2020 20:17 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 1,456 | $30.34 | $44,175.04 |
DisclosureSEC source: 0001209191-20-041974 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,706 Read SEC document |
| July 03, 2020 Filed Jul 6, 2020 23:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 373 | $32.19 | $12,006.87 |
DisclosureSEC source: 0001209191-20-041303 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,162 Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 23:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 377 | $32.34 | $12,192.18 |
DisclosureSEC source: 0001209191-20-041303 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,535 Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:43 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 12,058 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035640 · doc4.xml · derivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,058 Underlying: Common Stock · 12,058 shares Expires not disclosed F1 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. F1 · derivative.expiration_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 21:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 363 | $26.66 | $9,677.58 |
DisclosureSEC source: 0001209191-20-023315 · doc4.xml · nonDerivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,636 Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 28,223 | $0.00 Strike: $26.09 | $0.00 |
DisclosureSEC source: 0001209191-20-023315 · doc4.xml · derivative · entry 4 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,223 Underlying: Common Stock · 28,223 shares Expires 2030-04-01 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2020. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 8,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023315 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,999 F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2020. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:20 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 381 | $26.09 | $9,940.29 |
DisclosureSEC source: 0001209191-20-023315 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,183 Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 373 | $51.84 | $19,336.32 |
DisclosureSEC source: 0001209191-19-042102 · doc4.xml · nonDerivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,169 Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 377 | $52.27 | $19,705.79 |
DisclosureSEC source: 0001209191-19-042102 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,542 Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 435 | $52.88 | $23,002.80 |
DisclosureSEC source: 0001209191-19-042102 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,919 Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 21:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionPerformance Share Units · Derivative | 3,937 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-041724 · doc4.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,937 shares Expires 2019-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 1, 2016, the reporting person was granted 7,875 performance stock units that, to the extent earned, settle as common stock based on the Company's total shareholder return ("TSR"), in relation to the TSR of companies included within the S&P Healthcare Select Sector Index as of July 1, 2016, during the performance period of July 1, 2016 through June 28, 2019. On July 8, 2019 (the "Vesting Date"), the compensation committee of the Company's board of directors determined that the awards were achieved at 50% of target, resulting in 3,937 shares of common stock being earned by the reporting person. Under the terms of the award, delivery of the earned shares of common stock will be deferred until one year following the Vesting Date. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 21:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionCommon Stock | 3,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-041724 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 1, 2016, the reporting person was granted 7,875 performance stock units that, to the extent earned, settle as common stock based on the Company's total shareholder return ("TSR"), in relation to the TSR of companies included within the S&P Healthcare Select Sector Index as of July 1, 2016, during the performance period of July 1, 2016 through June 28, 2019. On July 8, 2019 (the "Vesting Date"), the compensation committee of the Company's board of directors determined that the awards were achieved at 50% of target, resulting in 3,937 shares of common stock being earned by the reporting person. Under the terms of the award, delivery of the earned shares of common stock will be deferred until one year following the Vesting Date. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 20:29 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026214 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,417 Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 20:34 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-024365 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,375 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 7,829 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023371 · doc4.xml · derivative · entry 4 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,829 Underlying: Common Stock · 7,829 shares Expires 2022-04-01 F4 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2019 to April 1, 2022. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 1, 2019, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 12,971 | $0.00 Strike: $56.20 | $0.00 |
DisclosureSEC source: 0001209191-19-023371 · doc4.xml · derivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,971 Underlying: Common Stock · 12,971 shares Expires 2029-04-01 F3 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 7,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023371 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,738 F2 · shares: Represents time-based vesting restricted stock units that vest on the second anniversary of the grant date, April 1, 2019. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023371 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,040 F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:14 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 3,481 | $57.06 | $198,625.86 |
DisclosureSEC source: 0001209191-19-019140 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,125 Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 20:14 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019140 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,606 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.